ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test
Are you or a loved one experiencing repeated episodes of paralysis on one or both sides of the body? It could be a sign of Alternating Hemiplegia of Childhood (AHC) type 1, a rare neurological disorder. At DNA Labs UAE, we offer the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test to help diagnose and manage this condition.
Test Components
The ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test includes:
- NGS Technology
- Neurological Disorders Test Type
- Genetics Test Department
Price
The cost of the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test is AED 4400.0.
Sample Condition
We accept the following sample conditions for this test:
- Blood
- Extracted DNA
- One drop of blood on FTA Card
Report Delivery
You can expect to receive your test report within 3 to 4 weeks.
Method
We utilize NGS (Next Generation Sequencing) technology to analyze the ATP1A2 gene for mutations associated with AHC type 1.
Test Type
The ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 Genetic Test is specifically designed for neurological disorders.
Doctor
Your test will be overseen by a Neurologist.
Test Department
This test is conducted by our Genetics Test Department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who will be undergoing the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test. Additionally, a Genetic Counseling session will be conducted to draw a pedigree chart of family members affected with AHC type 1. This information is crucial for accurate diagnosis and management of the condition.
Test Details
The ATP1A2 gene is associated with Alternating Hemiplegia of Childhood (AHC) type 1, a rare genetic disorder that affects the nervous system. This condition leads to repeated episodes of paralysis on one or both sides of the body. Our NGS genetic testing can analyze the ATP1A2 gene for mutations that may cause AHC type 1. This test can help diagnose individuals with symptoms and can also be used for carrier testing in family members of affected individuals. Early diagnosis and treatment are essential for managing symptoms and improving the quality of life for those with AHC type 1. Furthermore, this genetic test provides important information for family planning and reproductive decision-making.
Test Name | ATP1A2 Gene Alternating hemiplegia of childhood type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ATP1A2 Gene Alternating hemiplegia of childhood type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP1A2 Gene Alternating hemiplegia of childhood type 1 |
Test Details | The ATP1A2 gene is associated with a rare neurological disorder called Alternating Hemiplegia of Childhood (AHC) type 1. AHC is a rare genetic disorder that affects the nervous system and causes repeated episodes of paralysis on one or both sides of the body. NGS (Next Generation Sequencing) genetic testing can be used to analyze the ATP1A2 gene for mutations that may cause AHC type 1. This type of genetic testing can help diagnose AHC in individuals with symptoms and can also be used for carrier testing in family members of affected individuals. Early diagnosis and treatment can help manage symptoms and improve quality of life for individuals with AHC type 1. Genetic testing can also provide important information for family planning and reproductive decision-making. |